RenovoRx, Inc.
RNXT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001574094
No open-market purchases or sales by RenovoRx, Inc. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $9.00M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding RenovoRx, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 27 | 25 | −2 |
| Shares | 10.1M | 8.79M | −1.28M (−12.7%) |
| Value | $9.98M | $11.6M | +$1.60M (+16.1%) |
New holders (5)
Institutions that held RenovoRx, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Northwestern Mutual Wealth Management Co | 74,596 | $98.1K | 0.00% |
| Two Sigma Securities, LLC | 21,835 | $28.7K | 0.00% |
| HRT Financial LP | 20,632 | $27.0K | 0.00% |
| Captrust Financial Advisors | 12,307 | $16.2K | 0.00% |
| Capital Advisors Wealth Management, LLC | 10,000 | $13.2K | 0.00% |
Sold out (7)
Institutions that held RenovoRx, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Alyeska Investment Group, L.P. | 688,577 | $681.7K |
| Stonepine Capital Management, LLC | 278,188 | $275.4K |
| XTX Topco Ltd | 20,344 | $20.1K |
| Tower Research Capital LLC (TRC) | 3,683 | $3.65K |
| Boston Private Wealth LLC | 1,094 | $1.08K |
| Barclays PLC | 43 | $43 |
| JPMorgan Chase & Co | 36 | $36 |